The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Impact of COVID-19 on lung cancer in the UK
Robert Rintoul, PhD, FRCP, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; Chair of the UK Lung Cancer Coalition Clinical Advisory Group discusses how the COVID-19 pandemic has impacted lung cancer care in the UK. Problems include an increase in missed screenings and the fact that lung cancer symptoms overlap with COVID symptoms, both of which have resulted in delayed diagnoses for many patients, resulting in poorer outcomes.
